A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1994
12/28/1994	EP0630216A1 Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like
12/28/1994	EP0558525B1 Semduramicin premix
12/28/1994	CN1096786A Coumarin derivatives as retroviral inhibitors
12/28/1994	CN1027165C 7-(1-pyrrolidiny 1)-3-quinolone- and -naphthyridone-carboxylic acid derivatives, processes for their preparation and substituted mono- and bicyclic pyrrolidine derivatives as intermediate products....
12/27/1994	US5376644 Viricides
12/27/1994	US5376642 Treatment of retroviral induced dementia by administration of 2',3'-dideoxyinosine
12/27/1994	US5376634 Microbiocides
12/27/1994	US5376633 Using alpha 1-antitrypsin
12/26/1994	CA2126363A1 3-hydroxy-4-hydroxymethyl-2-methylenecyclopentyl purines and pyrimidines
12/26/1994	CA2113700A1 2-(3-oxoalk(en)yl)-3-isothiazolones and derivatives as antimicrobial agents
12/22/1994	WO1994029473A1 Aids virus multiplication inhibitor and method of culturing active ingredient thereof
12/22/1994	WO1994029472A2 Mengovirus as a vector for expression of foreign polypeptides
12/22/1994	WO1994029439A1 High yielding influenza viruses
12/22/1994	WO1994029436A1 Methods for selectively stimulating proliferation of t cells
12/22/1994	WO1994029348A2 Production of antibody fragments
12/22/1994	WO1994029347A1 Antibody fragments in therapy
12/22/1994	WO1994029339A1 Tandem synthetic hiv-1 peptides
12/22/1994	WO1994029320A1 Cephalosporin compound, process for producing the same, and intermediate compound
12/22/1994	WO1994029308A1 Lavendamycin analogs, their use and preparation
12/22/1994	WO1994029304A1 Thienylthiazole derivatives
12/22/1994	WO1994029301A1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
12/22/1994	WO1994028929A1 Hiv envelope polypeptides
12/22/1994	WO1994028928A1 Novel attenuated pseudomonas aeruginosa strains
12/22/1994	WO1994028920A1 Synthetic peptide inhibitors of hiv transmission
12/22/1994	WO1994028916A1 Release and mobilisation of haematopoietic cells
12/22/1994	WO1994028911A1 COMPOSITIONS FOR USE IN THE REGULATION OF SUBNORMAL pH VALUES IN THE INTESTINAL TRACT AND FOR TREATMENT OF BOWEL DISEASES
12/22/1994	WO1994028898A1 H2-antagonists as immune stimulants in bacterial infections of cattle or swine
12/22/1994	WO1994028885A1 Diamondoid derivatives for pharmaceutical use
12/22/1994	WO1994028726A2 Method of treating retained pulmonary secretions
12/22/1994	WO1994028714A1 Method of killing fungi, yeast or bacteria with selected monocyclic monoterpenes
12/22/1994	WO1994025596A3 Immunogenic formulation of ospc antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
12/22/1994	WO1994025477A3 Novel peptide nucleic acids
12/22/1994	WO1994017773A3 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
12/22/1994	DE4401419C1 Secretion of proteins of the outer membrane of Gram-negative bacteria by means of Gram-positive host organisms
12/22/1994	CA2165344A1 Immune stimulants in bacterial infections
12/22/1994	CA2164969A1 Method of killing fungi, yeast or bacteria with selected monocyclic monoterpenes
12/22/1994	CA2164946A1 High yielding influenza viruses
12/22/1994	CA2164606A1 Compositions for use in the regulation of subnormal ph values in the intestinal tract and for treatment of bowel diseases
12/22/1994	CA2164505A1 Hiv envelope polypeptides
12/22/1994	CA2164297A1 Mengovirus as a vector for expression of foreign polypeptides
12/21/1994	EP0629696A1 Recombinant DNA-derived bordetella toxin subunit analogs
12/21/1994	EP0629636A1 Lipopeptides from actinoplanes sp. endowed with pharmacological activity, process for their preparation and their use
12/21/1994	EP0629633A2 Dinucleotide analogues, intermediates therefor and oligonucleotides derived therefrom
12/21/1994	EP0629625A1 Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
12/21/1994	EP0629406A1 Medicament for the treatment of sepsis or septic shock
12/21/1994	EP0629404A1 Pharmaceutical composition containing cefditoren pivoxil
12/21/1994	EP0629403A1 Antibiotic combination
12/21/1994	EP0629240A1 Altered antibodies, products and processes relating thereto
12/21/1994	EP0629208A1 Fluorosugar derivatives of macrolides
12/21/1994	EP0629204A1 Cephalosporin derivatives
12/21/1994	EP0629203A1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents
12/21/1994	EP0629132A1 PURIFIED VACUOLATING TOXIN FROM $i(HELICOBACTER) PYLORI AND METHODS TO USE SAME
12/21/1994	EP0629131A1 ANTIGENS PROTECTIVE AGAINST $i(ECHINOCOCCUS GRANULOSUS) INFECTION AND VACCINES CONTAINING SUCH ANTIGENS
12/21/1994	EP0579763A4 Novel peptide compositions and uses therefor.
12/21/1994	CN1096516A Improved meningococoal polysaccharide conjugate vaccine
12/21/1994	CN1027068C Alpha-substituted 4-(quinolin-2-yl-methoxy)-phenylacetic acide and-esters
12/20/1994	US5374719 Process for converting loracarbef dihydrate to loracarbef monohydrate
12/20/1994	US5374552 Pure culture of Actinomadura species, mutants
12/20/1994	CA1333601C Macrolide compounds
12/20/1994	CA1333600C Process for the preparation of macrolide compounds
12/20/1994	CA1333571C Preventing agent for human immunodeficiency virus infection comprising menfegol
12/20/1994	CA1333562C Preservation of viruses
12/18/1994	CA2125121A1 Antibiotic Combination
12/17/1994	CA2125936A1 Pharmaceutical composition
12/16/1994	CA2125762A1 Loracarbef hydrochloride c1-c3 alcohol solvates and uses thereof
12/16/1994	CA2102003A1 1-.beta.-methyl-2-thiolic carbapenem derivatives
12/14/1994	EP0628572A2 DNA originating in non-A non-B hepatitis virus gene and constituting polypeptide
12/14/1994	EP0628562A1 Cephalospornis having in position 7 as substituted axymino radical, intermediates, processes for their preparation and their use as medicaments
12/14/1994	EP0628561A1 Process for preparing cephalosporin compounds from reactive organic acid derivatives
12/14/1994	EP0628555A1 Substituted (2-oxo-1-benzimidazolinyl)-piperidines, process for their preparation and their use as antiretroviral agents
12/14/1994	EP0628310A1 Use of partially known substituted chromanes as medicine, new products and process for their preparation
12/14/1994	EP0628079A1 Hepatitis c virus peptides
12/14/1994	EP0628056A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections
12/14/1994	EP0628053A1 Hepatitis e virus peptide antigens and antibodies
12/14/1994	EP0628047A1 Novel therapeutical use of pyridylpyrrolothiazole carboxamide derivatives
12/14/1994	EP0628044A1 Therapeutic nucleosides
12/14/1994	EP0628035A1 Retroviral protease inhibitors
12/14/1994	EP0627936A1 Feline infectious peritonitis vaccine and method of preparation
12/14/1994	EP0627920A1 Novel and prior art disulphides and their use in the control of helicobacter bacteria
12/14/1994	EP0496813B1 Liposome microreservoir composition and method
12/14/1994	CN1096298A New cephalosporins containing a substituted oxyimino radical in position 7, their preparation process and intermediates and their use as medicaments
12/14/1994	CN1096223A Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases
12/13/1994	US5372808 Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
12/13/1994	CA1333471C Whey protein concentrate as food supplement
12/11/1994	CA2111164A1 Cephatosporins containing a 7-substituted oxyimino radic al, their preparation process and intermediates and their use as drugs
12/08/1994	WO1994028391A1 Ligands for flt3 receptors
12/08/1994	WO1994028153A2 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
12/08/1994	WO1994028137A1 Regulator of contact-mediated hemolysin
12/08/1994	WO1994028134A1 Lymphocyte chemoattractant factor and uses thereof
12/08/1994	WO1994028025A1 Methods and compositions for inhibiting cd14 mediated cell activation
12/08/1994	WO1994028002A1 36-derivatives of rifamycins and their use as antimicrobial agents
12/08/1994	WO1994028001A1 Thiomarinol derivatives, process and intermediates for their preparation and their use as microbicides and herbicides
12/08/1994	WO1994028000A1 Calanolide and related antiviral compounds, compositions, and uses thereof
12/08/1994	WO1994027988A1 Optically pure salts of pyridinylmethyl sulfinyl-ih-benzimidazole compounds
12/08/1994	WO1994027976A1 Triazole derivative or salt thereof, and fungicide containing the same
12/08/1994	WO1994027952A1 Novel antiviral agents
12/08/1994	WO1994027642A1 Hepatotropic conjugates of antiviral drugs, carriers thereof and pharmaceutical compositions containing them
12/08/1994	WO1994027636A1 Adjuvants for vaccines against respiratory syncytial virus
12/08/1994	WO1994027627A1 Hemoregulatory peptides
12/08/1994	WO1994027616A1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents

1 ... 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 ... 1798